Zai Lab Licenses MediLink Therapeutics' Antibody-Drug Conjugate Platform
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.43 USD | -0.36% |
|
+0.88% | +4.73% |
Jan. 23 | Asian Equities Traded in the US as American Depositary Receipts Ease in Thursday Trading | MT |
Jan. 23 | Zai Lab Says FDA Grants Orphan Drug Designation for ZL-1310 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration